Tripathi S, Malhotra A, Qazi M, Chou J, Wang F, Barkan S, Hellmers N, Henchcliffe C, Sarva H.
2022.
Clinical Review of Smartphone Applications in Parkinson's Disease.. Neurologist. 27(4):183-193.
Flory JH, Small DS, Cassano PA, Brillon DJ, Mushlin AI, Hennessy S.
2014.
Comparative effectiveness of oral diabetes drug combinations in reducing glycosylated hemoglobin.. J Comp Eff Res. 3(1):29-39.
Konnaris MA, Brendel M, Fontana MAlan, Otero M, Ivashkiv LB, Wang F, Bell RD.
2022.
Computational pathology for musculoskeletal conditions using machine learning: advances, trends, and challenges.. Arthritis Res Ther. 24(1):68.
Konnaris MA, Brendel M, Fontana MAlan, Otero M, Ivashkiv LB, Wang F, Bell RD.
2022.
Computational pathology for musculoskeletal conditions using machine learning: advances, trends, and challenges.. Arthritis Res Ther. 24(1):68.
Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al..
2019.
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.
Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al..
2019.
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.
Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al..
2019.
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.
Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al..
2019.
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.
Behrends CN, Eggman AA, Gutkind S, Bresnahan MP, Fluegge K, Laraque F, Litwin AH, Meissner P, Shukla SJ, Perumalswami PV et al..
2019.
A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination.. J Public Health Manag Pract. 25(3):253-261.
Behrends CN, Eggman AA, Gutkind S, Bresnahan MP, Fluegge K, Laraque F, Litwin AH, Meissner P, Shukla SJ, Perumalswami PV et al..
2019.
A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination.. J Public Health Manag Pract. 25(3):253-261.
Kim M-H, Chang J, Kim WJunsuk, Banerjee S, Park SMin.
2018.
Cumulative Dose Threshold for the Chemopreventive Effect of Aspirin Against Gastric Cancer.. Am J Gastroenterol. 113(6):845-854.
Brandt PS, Pacheco JA, Adekkanattu P, Sholle ET, Abedian S, Stone DJ, Knaack DM, Xu J, Xu Z, Peng Y et al..
2022.
Design and validation of a FHIR-based EHR-driven phenotyping toolbox.. J Am Med Inform Assoc. 29(9):1449-1460.
Brandt PS, Pacheco JA, Adekkanattu P, Sholle ET, Abedian S, Stone DJ, Knaack DM, Xu J, Xu Z, Peng Y et al..
2022.
Design and validation of a FHIR-based EHR-driven phenotyping toolbox.. J Am Med Inform Assoc. 29(9):1449-1460.